Are heterogenous results of EGFR immunoreactivity in renal cell carcinoma related to non-standardised criteria for staining evaluation?

Journal of Clinical Pathology
C LangnerR Zigeuner

Abstract

To assess whether heterogeneity of epidermal growth factor receptor (EGFR) immunoreactivity in renal cell carcinoma (RCC) is related to non-standardised criteria for staining evaluation. EGFR expression was investigated in 132 primary and 55 metastatic conventional RCCs using a tissue microarray technique. Overall, membranous and/or cytoplasmic EGFR immunostaining was present in 123 of 132 (93%) primary and 49 of 53 (92%) metastatic RCCs, with extensive immunoreactivity (> 50% of tumour cells) in 110 of 132 (83%) primary tumours and 39 of 53 (73%) metastases. Cytoplasmic staining was associated with high tumour stage and high tumour grade. In addition, strong membranous staining (score 3+) prevailed in high grade RCCs. Cytoplasmic immunostaining was associated with an unfavourable prognosis, whereas overall (cytoplasmic and membranous) immunoreactivity and intensity of membranous staining were not. Different methods of immunohistochemical evaluation led to different results, strengthening the need for standardisation, especially against a background of rapidly evolving EGFR targeted cancer treatment strategies.

References

Jul 14, 1998·Nature Medicine·J KononenO P Kallioniemi
Jan 27, 2000·The Journal of Urology·R J Motzer, P Russo
Jul 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John Mendelsohn, Jose Baselga

❮ Previous
Next ❯

Citations

Mar 24, 2006·Pathology Oncology Research : POR·László Kopper, József Tímár
Mar 25, 2011·International Journal of Clinical Oncology·Derek ShekPrimo N Lara
Aug 3, 2012·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·K Matušan-IlijašK Lučin
May 28, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A P Dei Tos, I Ellis
Jan 29, 2011·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Giovanna GiordanoCarla Merisio
May 9, 2009·Journal of Oncology·Amir HarandiDamian A Laber
Dec 4, 2012·International Journal of Molecular Sciences·Guadalupe Aparicio GallegoLuís M Antón Aparicio
Sep 27, 2008·Annals of Surgical Oncology·Sebastian HoffmannAndreas Zielke
Mar 14, 2009·European Urology·S GattenlöhnerH-K Müller-Hermelink
Feb 8, 2008·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Sebastian LeiblCord Langner
Jan 15, 2010·International Journal of Cancer. Journal International Du Cancer·Hirotaka FukasawaAkira Hishida
Sep 9, 2010·International Journal of Cancer. Journal International Du Cancer·Alexandre Ho-Pun-CheungEvelyne Lopez-Crapez
Aug 19, 2015·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Afkar Abdel-Ghany BadawyNoha Said
Apr 22, 2014·Human Pathology·Beatriz de Melo MaiaRafael Malagoli Rocha
Dec 1, 2006·Expert Review of Anticancer Therapy·Jacques Bernier
Oct 18, 2007·British Journal of Cancer·M FrattiniL Mazzucchelli
Mar 2, 2006·British Journal of Cancer·P NathanT Eisen
Jan 19, 2006·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P SchöffskiH Van Poppel
Aug 28, 2021·International Journal of Molecular Sciences·Maria Rosaria MuroniMaria Rosaria De Miglio

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.